Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. (2019)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/infdis/jiy726
PubMed Identifier: 30566691
Publication URI: http://europepmc.org/abstract/MED/30566691
Type: Journal Article/Review
Volume: 219
Parent Publication: The Journal of infectious diseases
Issue: 11
ISSN: 0022-1899